China's Sinovac Biotech has secured approximately USD500 million in funding for Covid-19 vaccine development from Sino Biopharmaceutical.
In a statement, the company said it expects to be able to manufacture 300 million vaccine doses annually, and aims to complete construction of a second production facility by the end . . .
Please Login to read all contents for free.
Lee Kian Soon, CEO of Astral Asset Management Singapore, shares his insights on regional markets performance as well as touches...
Read moreWith the global population predicted to grow to approximately 10 billion by 2050, one of the biggest challenges is ensuring...
Read moreCharu Chanana, Market Strategist from Saxo Markets Singapore, shares her insights on regional markets performance as well as other key...
Read moreFounded on August 29, 1975 and headquartered in Stockholm, Sweden, Hexagon is a global leader in digital reality solutions, combining...
Read more
© 2022 Biztech Asia - Powered by Milestones.digital.
Home
Health and Wellness Shows (Malaysia) 
Health and Wellness Shows (Indonesia) 
Health and Wellness Shows (Singapore)